Cost of Oncology Drugs in the Middle-Eastern Country of Lebanon: An Update (2014-2016)

This study aims to evaluate trends in the increasing costs of oncology drugs procured by the Lebanese Ministry of Public Health (MOPH) between 2014 and 2016 and to assess the impact of the introduction in mid-2015 of new immunotherapy drugs for the treatment of lung cancer on the overall and specific costs of that treatment.A secondary analysis of data from the MOPH Cancer Drug Scientific Committee data base was conducted using a total of 18,133...